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Abstract
Background: In the northern hemisphere winter of 2003–04 antigenic variant strains (A/Fujian/411/02 –like) of influenza A
H3N2 emerged. Circulation of these strains in the UK was accompanied by an unusually high number of laboratory
confirmed influenza associated fatalities in children. This study was carried out to better understand risk factors associated
with fatal cases of influenza in children.
Methodology/Principal Findings: Case histories, autopsy reports and death registration certificates for seventeen fatal
cases of laboratory confirmed influenza in children were analyzed. None had a recognized pre-existing risk factor for severe
influenza and none had been vaccinated. Three cases had evidence of significant bacterial co-infection. Influenza strains
recovered from fatal cases were antigenically similar to those circulating in the community. A comparison of protective
antibody titres in age stratified cohort sera taken before and after winter 2003–04 showed that young children had the
highest attack rate during this season (21% difference, 95% confidence interval from 0.09 to 0.33, p=0.0009). Clinical
incidences of influenza-like illness (ILI) in young age groups were shown to be highest only in the years when novel
antigenic drift variants emerged.
Conclusions/Significance: This work presents a rare insight into fatal influenza H3N2 in healthy children. It confirms that
circulating seasonal influenza A H3N2 strains can cause severe disease and death in children in the apparent absence of
associated bacterial infection or predisposing risk factors. This adds to the body of evidence demonstrating the burden of
severe illness due to seasonal influenza A in childhood.
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Introduction
Influenza A virus is a cause of severe morbidity and mortality
worldwide [1,2]. In the developed world, most influenza-
associated deaths occur in the elderly but fatal outcomes occur
regularly in young adults and children [3,4].
Human seasonal influenza A viruses evolve rapidly through
genetic mutation, allowing them to escape previously acquired
immunity [5]. Viral variants that are altered in their antigenic
properties emerge frequently, a phenomenon described as
antigenic drift, which is particularly marked with human
influenza A H3N2. A/Fujian/411/02-like influenza A H3N2,
first noted in sporadic cases of returning U.K. travellers in early
summer 2003 [6] was antigenically distinguishable from the
previously circulating H3N2 drift variant, A/Panama/2007/99
and replaced it to became the only circulating strain in winter
season 2003–04 [7].
This study investigated fatal cases of influenza H3N2 in children
during the emergence of A/Fujian/411/02 in the UK in winter
2003–04. The goals of the study were: to investigate whether any
of the case fatalities had underlying disease or risk factors; to
evaluate how laboratory confirmed infections were recorded in
death certification; to describe the clinical and pathological
findings in relation to circulating virus strains; and to investigate
whether the high number of laboratory confirmed fatalities was
reflected in measures of morbidity in primary care, age specific
attack rates and age specific all-cause mortality. We reviewed the
antecedent illness history, underlying risk factors, clinical findings
and observed pathology at autopsy. Age-stratified serological data
were combined with community based clinical morbidity data to
provide an assessment of the overall population immune
susceptibility, attack rates and impact of A/Fujian/411/02-like
influenza in comparison with other winter seasons in which new
H3N2 antigenic variants emerged.
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Ethics statement
This study was conducted as part of a public health inquiry by
the Health Protection Agency and Health Protection Scotland into
paediatric deaths, where it was agreed that ethical approval for
linking personal clinical outcome information to virus strains was
not required. Nationally representative, anonymised, age stratified
residual sera were obtained from the HPA serum bank held in
Preston NHS hospital. Ethical approval was given by the HPA for
the collection of these samples.
Case definition and confirmation of influenza virus
infection
A case was defined as a death in child less than eighteen years of
age during the 2003–04 influenza season (1
st September 2003 to
30
th May 2004) with laboratory confirmation of influenza virus
infection reported to HPA. Most specimens were initially tested at
referring hospitals, and all were subsequently tested at the
national influenza laboratory, HPA Centre for Infection, Colin-
dale (HPA CfI). Microbiological findings deemed significant are
included.
Demographic and Clinical Characteristics
Health care providers contacted local public health authorities
and HPA CfI to report cases. Available clinical records
and data, autopsy reports and microbiology results were obtained
as part of the public health investigation for all cases and were
reviewed by a senior paediatrician and other specialist medical
staff (all of whom are authors on this paper). The activity took
place within the context of a national public health enquiry
into influenza associated childhood deaths in winter 2003.
Children without risk factors recognized by UK Joint Committee
on Vaccination and Immunisation to increase the risk of influenza
related complications were classified as ‘‘previously healthy’’.
U.K. risk factors for severe influenza from 2003–04
are given in reference 12. Verification of the certified cause of
death in each fatal case was performed by matching cases to
Office of National Statistics (ONS) death registration records held
at HPA.
Surveillance data, clinical incidence data for influenza-like
illness (ILI) and death registration data
The Weekly Returns Service (WRS) of the Royal College of
General Practitioners is a clinical information system based upon
a network of sentinel general practices located throughout
England and Wales [8]. Mean weekly incidence rates per
100,000 population for first and new episodes of ILI (ICD9 487)
were calculated for ‘‘influenza virus active weeks’’ during each
winter (weeks 40 to 20) as previously described [8]. Data were
aggregated into the age groups; all-age, 0–4, 5–14, 15–44, 45–64
and 65+ years. Surveillance data about circulating influenza
viruses in the U.K. is recorded weekly in the HPA National
Influenza Report, available online at http://www.hpa.nhs.uk/
web/HPAweb&HPAwebStandard/HPAweb_C/1195733836222.
Cells and viruses
Viruses were grown in either MDCK or MDCK-SIAT1 cells
and subtyping was performed by RT-PCR, if no virus isolate was
available [9]. Virus isolates were characterized antigenically using
post infection ferret antisera using haemagglutination inhibition
(HI) assays [10].
Age Stratified Sera
Nationally representative, anonymised, age stratified residual
sera were obtained with ethical approval from the HPA serum
bank held in Preston NHS hospital. The number of sera tested
from 2003 was 88 (ages 0–4), 196 (ages 5–17), 293 (ages 18–44),
185 (ages 45–64) and 101 (ages 65+). The number of sera from
2004 for each age group was 70 (ages 0–4), 160 (ages 5–17), 273
(ages 18–44), 199 (ages 45–64) and 98 (ages 65+).
Haemagglutination Inhibition Assay
Haemagglutination inhibition (HI) assays to assess protective
antibody titres in human sera were performed using standard
protocols and antigenically representative viruses. A titre of .1/40
was taken as protective.[11] The proportion of sera in 2003 and
2004 with protective antibody titre were compared using a 2-sided
Fisher’s exact P (p values are indicated).
Results
Clinical Findings
Seventeen fatal cases of laboratory-confirmed influenza A in
children under eighteen years were reported to HPA between
September and December 2003. This period corresponded with
peak circulation of influenza during the winter 2003–04. The
median age of fatal cases was two years, with a range from four
months to seventeen years; the majority (64%) were under five
years. Ten (58%) deaths were in females. The duration of illness
prior to death varied, with a median duration of three days (range
0–14 days). Four (24%) deaths were sudden with either no
recognized antecedent illness or illness of less than 6 hours
duration. A further four (24%) occurred within forty-eight hours of
onset of symptoms, five (29%) were ill for three to four days prior
to death, three (18%) were ill for a week prior to death, and one
individual was unwell for over ten days. Eight (47%) children died
following hospitalization and nine (53%) died in the community.
In the cases with recognized antecedent illness, eight (57%) had
fever, eleven (79%) had respiratory symptoms (cough/chest
infection/croup), three (21%) had vomiting and/or diarrhea,
two (14%) had clinically recognized sepsis. Two (14%) children
were markedly confused prior to collapse (Table 1).
Among the sixteen cases for whom underlying health status
information was available none was recorded as having a known
risk factor for severe influenza, although two cases (both over two
years) had a history of febrile convulsions [12]. No child received
influenza vaccine for winter 2003–04.
In nine cases (53%) influenza A detection occurred by more than
one method (RT-PCR, DIF or virus isolation), either in respiratory
clinical samples or from post-mortem tissues. In eleven (64%) cases
influenza A virus isolates were recovered. The cultured viruses were
analyzed for their antigenic characteristics; all isolates were found to
be antigenically similar to each other and to virus isolates recovered
from non-fatal cases matched for age, week of infection and
geographical location (controls) as well as to other circulating strains
from the same locality (data not shown). Influenza AH3N2 was
detected by RT-PCR only in five (29%) cases.
Staphylococcus aureus and Streptococcus pneumoniae in blood were
identified in the two cases of clinical sepsis and one case had
Streptococcus pneumonia bacterial pneumonia. No other significant
bacteriological findings were described. Enterovirus and norovirus
were also detected by RT-PCR in two cases.
Autopsy reports were available for all cases (Table 1). All cases
showed involvement of the airways including congestion, epiglottitis,
ulcerative tracheitis, bronchitis, tracheobronchitis bronchopneumo-
nia, pneumonitis, unilateral or bilateral pneumonia. Lung pathology
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alveolardamage,pulmonaryedema,lunginfiltrates,pleuraleffusions,
hemorrhagic pneumonia and lung collapse. Extra-pulmonary
pathology included two cases (12%) with marked cerebral edema
suggestive of hypoxia, sepsis in two cases (12%) due to Staphylococcus
aureus or Streptococcus pneumoniae and myocarditis in two cases (12%).
Eight cases (47%) showed abnormalities of the lymphoid system,
including seven (41%) with enlargement of the lymph nodes (LN),
thymus or spleen, six (35%) with hemorrhagic LN, thymus or spleen
and two (12%) with ‘‘starry sky’’ LN indicating an infiltration of
macrophages in the lymphoid tissue. No metabolic disorders were
recognized ante or post mortem, although one case showed unusual
large fiber laryngeal musculature of uncertain significance.
Death registration
Death registration information was not available for one case.
By routine death registration only nine of sixteen fatal cases (56%)
were coded with influenza (ICD10 J10–J11). Seven of these
specifically mentioned influenza A on the death certificate and a
further certificate mentioned ‘‘influenza’’ when text was searched
manually. Two (13%) of the deaths were registered as pneumonia
(J18); two (13%) as other respiratory disorders (J98); two (13%)
were registered as sudden infant death (SIDS) and one as acute
myocarditis, without mention of influenza (I40). Septicemia (A41)
and myocarditis (I40, I514) were identified as contributing causes
to death on three certificates. No death certificate indicated any
chronic medical conditions known to increase the risk of severe
disease from influenza infection.
Analysis of the age related susceptibility to influenza A
H3N2 infection
We sought to establish whether young children showed
particular susceptibility to A/Fujian/411/02-like virus infection
during this winter season by analyzing sera from summers 2003
and 2004, prior and subsequent to the emergence of this antigenic
drift variant. Serum samples in a nationally representative age-
stratified serum cohort were analyzed for the presence of
protective antibodies (figure 1). The number of individuals (all
ages) with a HAI titre .1/40 increased from 207/863 (24%) in
2003 to 348/800 (34%) in 2004 (p,0.0001). The largest increase
was seen in children under the age of four years, where the
number of individuals with a titre .1/40 rose from 25/88 (28%)
in 2003 to 44/70 (63%) in 2004 (p,0.01). This compares to 304/
730 (42%) of individuals over 4 years with a HAI titre .1/40 in
2004 (21% difference, 95% confidence interval from 0.09 to 0.33,
p=0.0009). This shows that those aged less than 4 years in 2004
were significantly more likely to have been infected with the novel
strain A/Fujian/411/02-like influenza during winter 2003–04.
Table 1. Summary of fatal paediatric cases of influenza H3N2 from 2003–04.
Case No.
Time between
illness onset
and death Clinical illness Post Mortem Findings
1 7 days Flu like symptoms for several days with vomiting
and diarrhoea.
Congested larynx and trachea. No focal consolidation. Enlarged liver.
2 Sudden Death Few hours temperature, vomiting, confusion and
rapid collapse. Cerebral oedema CT scan.
Patchy intraalveolar haemorrhage. Hypoxia & swollen brain. Norovirus detected.
3 3–4 days Vomiting over several days. Rapid collapse and
terminal deterioration.
Acute bronchitis and early bronchopneumonia. Intraalveolar haemorrhage.
Staphlococcus aureus septicaemia.
4 1–2 Mild respiratory illness. Sudden death. Diffuse alveolar damage and intraalveolar haemorrhage. Tracheobronchitis.
Enterovirus detected
5 7 days Mild illness. Hypothermia and circulatory collapse,
terminal deterioration.
Widespread myocarditis. Tracheobronchitis. Pulmonary oedema. Pleural effusion.
6 14 days Fever, cough and chest infection. Cardiac arrest. Pulmonary oedema Bilateral pulmonary & pericardial effusion. Diffuse widespread
myocarditis. ‘‘Starry sky’’ and haemorrhagic lymph nodes with lymphadenopathy.
7 1 day Sore throat and temperature. Sudden collapse. Tracheitis and Epiglottitis. Lung congestion Peribronchial infiltrate.
Lymphadenopathy, haemorrhagic spleen. Acute hypoxia/ischaemia in the brain
8 Sudden Death No. Bronchopneumonia
9 4 days Ear infection. Fever, cough and cold. Collapse. Tracheal ulceration and epiglottitis. Intraalveolar haemorrhage Lung infiltrates.
Haemorrhagic spleen
10 Sudden Death No. Tracheitis. Intrapulmonary haemorrhage. Enlarged, haemorrhagic thymus
11 Sudden Death No. Tracheitis. Intraalveolar haemorrhage. Unusual laryngeal musculature.
12 3 days Cough for few days. Apnoea. Bilateral pleural effusions. Pulmonary oedema. Severe ulcerative tracheitis.
Lymphadenopathy
13 2 days Fever and tachypnoea. Congested lungs. Severe ulcerative tracheitis. Starry sky lymph nodes.
Haemorrhagic thymus. Enlarged spleen.
14 3 days Croup like illness 2–3 days. Tracheobronchitis. Interstitial haemorrhage. Streptococcus pneumoniae septicaemia.
15 7 days Flu like illness and lethargy. Bronchopneumonia with intraalveolar haemorrhage, necrosis and secondary.
Streptococcal pneumonia. Lymphadenopathy
16 3 days Mild respiratory illness. Lethargy then haemopytsis.
Chest X-ray consolidation
Haemorrhagic pneumonia.
17 1 day High temperature and lethargy. Brain oedema and lung collapse. Lymphadenopathy and haemorrhagic lymph
nodes.
doi:10.1371/journal.pone.0007671.t001
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To assess the morbidity of influenza in different age groups we
analysed observational clinical data from primary care recorded
by GPs of the Weekly Returns Service (WRS). This is a national
sentinel network which has been recording influenza-like illness
(ILI) for over 40 years, and for which linked clinical-virological
surveillance has been operational since 1994. The all-age
incidences of ILI in England and Wales over a ten year period
from 1994–2004, together with incidence rates in children ages 0–
4 and 5–14 years is shown in Figure 2. During the ten year period,
there were only three seasons where the incidence of morbidity in
children aged 0–4 years exceeded the all-age incidences (marked
by arrows). All three seasons corresponded to the emergence of
significant antigenic drift variants of influenza A H3N2 in 1995–96
(A/Wuhan/359/95), 1997–98 (A/Sydney/5/97) and 2003–04
(A/Fujian/411/02). During this period of time there were no
other new H3N2 drift variants which emerged and dominated
virus circulation. The mean weekly incidence rates of ILI were
compared for different age groups during these influenza seasons,
together with 1999–2000 as an example of a winter season with a
dominance of circulating influenza A H3N2 and high population
morbidity (Figure 2), but where a new drift variant did not emerge.
The emergence of significant antigenic drift variants in 1995–96,
1997–98 and 2003–04 was accompanied by the highest incidences
of ILI in those aged 0–4 years (Figure 3A, B and D). The season
2003–04 was notable for the fact that population morbidity rates
in young children aged 0–4 were more than twice those of the
overall all-age morbidity, indicating substantial disease burden in
the young. This is consistent with the serological findings of the
highest age specific attack rates having occurred in the youngest
age groups during this winter period. In the winter 1999–00,
where a new antigenic drift variant did not emerge, the highest
rates of ILI morbidity rates were recorded in the older age groups
45–64 and 65 and over (Figure 3C).
Discussion
Winter 2003–04 was marked by an unusually high number of
severe and fatal cases of influenza in the young, following the
emergence of the influenza A H3N2 antigenic drift variant A/
Fujian/411/02 [6]. The cases all occurred in children without
known risk factors and for whom no vaccination would be
recommended. The greatest susceptibility to the drift variant was
in the youngest age group as demonstrated by age specific attack
rates estimated serologically. This conclusion correlated with a
separate determination of population morbidity recorded in
primary care during the peak periods of virus circulation during
the 2003–04 winter period, although there was no increase in all-
Figure 1. Age-distribution of seroconversion to influenza virus
in 2003 and 2004. Charts show the proportion of sera from the
summers of 2003 (clear bars) and 2004 (filled bars) that gave a HI titre
above 1/40 for each age group against A/Wyoming/3/03 (antigenically
equivalent to A/Fujian/411/02), together with the 95% confidence
interval (error bars). Asterisks denote statistical significance (*p,0?05;
**p,0?01). A total of 882 and 799 serum samples were tested for 2003
and2004respectively,eachinduplicate,togetherwithcontrolferretsera.
doi:10.1371/journal.pone.0007671.g001
Figure 2. Clinical incidence rate of influenza-like illness (ILI) per 100,000 population recorded by the Royal College of General
Practitioners Weekly Returns Service. Weekly incidence rate of ILI presented for all-age, 0–4 and 5–14 years age groups. Vertical shaded bars
represent defined periods of influenza virus circulation derived from laboratory reports.[8] Arrows indicate those years in which a new variant was
introduced into the community (1. A/Wuhan/359/95; 2. A/Sydney/5/97; 3. A/Fujian/411/02).
doi:10.1371/journal.pone.0007671.g002
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observations). Over a ten year period, years that had the highest
population morbidity in the youngest age groups were those that
saw the emergence and circulation of novel H3N2 antigenic drift
variants. Together, this suggests that the most vulnerable
individuals are those with the least immunity to influenza as a
result of limited prior exposure to circulating strains, and we
suggest that a gradual build up of immunity as a result of exposure
correlates with protection in the face of a novel drift variant.
Therefore, the emergence of drift variants or pandemic influenza
strains will cause higher morbidity and mortality rates in young
children due to the lack of cross reactive immunity, either cellular
or humoral, raised during a previous natural infection. It is
interesting to note that in a recent study of the current outbreak of
novel swine-origin influenza A (H1N1), 60% of patients were 18
years of age or younger [13].
The range of clinical complications in UK fatal cases can be
grouped into categories including (1) fulminant progression to
death after an initially mild illness, (2) invasive bacterial infection,
(3) respiratory tract complications and (4) non respiratory
complications including myocarditis and encephalopathy. Extra-
pulmonary complications of myocarditis and encephalopathy were
not accompanied by the detection of viral RNA from brain or
heart tissue by RT-PCR, although virus was recovered from the
nasopharynx. The pathological conclusions rest on histology
findings, which suggests that tissue damage may occur through
mechanisms other than direct viral replication, as has been
previously suggested [14].
The clinical microbiological findings add to the debate about
the importance of bacterial co-pathogens in influenza associated
fatality. Only three (18%) of the fatal cases showed evidence of
significant bacterial co-infection. This is similar to findings from
fatal cases in the US 2003–04 and also to preliminary information
from the current outbreak of swine-origin influenza A H1N1,
where a minority of paediatric hospital admissions had possible or
probable bacterial infection [3,15]. This is substantially less than
the figures for the 1918 (96%) or 1957 (75%) influenza pandemics
[14,16] or during the 2008–09 influenza season in the USA, where
six (66.7%) out of nine reported deaths in children had bacterial
coinfections, mainly Staphylococcus aureus [17]. It is possible that
treatment with antibiotics in 2003–04 may have masked the
contribution of bacterial pathogens to pathology, or that the post
mortem bacteriological findings have been underestimated,
although at least half of the fatal cases died without any
therapeutics. Disparities in the assessment of contribution played
by bacterial co-pathogens may reflect differences between adult
and child fatal case series, and may also be due to variations
between different strains of influenza.
In this case series over 40% of death certificates had no mention
of influenza as a direct or indirect cause of death, and in over 70%
of cases the diagnosis of influenza was not made until post mortem
tissue was examined. The burden of influenza in young children is
therefore under recognized, precisely because few influenza
infections are recognized clinically [4]. Of the cases reported to
HPA and Health Protection Scotland during 2003–2004,
seventeen were laboratory confirmed for A/Fujian/411/02-like
influenza. This number is not comprehensive and is likely to
underestimate the number of fatal cases that occurred. Recogni-
tion of influenza can provide the opportunity for improved
infection control, vaccination and antiviral therapy. Use of
national mortality registration data to estimate deaths due to
influenza in childhood will seriously underestimate the impact of
influenza even if all cause mortality is considered.
A risk-factor based influenza vaccination program for children
would not prevent these fatal cases as the reasons underlying
susceptibility to severe disease remain cryptic. Further studies on
the outcome of seasonal influenza in children will help us to
predict the impact of future epidemics and will assist understand-
Figure 3. Clinical incidence rate of influenza-like illness (ILI) by age group expressed as a factor of the all-age incidence rate. Mean
weekly incidence rates of ILI during influenza virus active weeks were calculated for winters: A) 1995/96 (A/Wuhan/359/95); B) 1997/98 (A/Sydney/5/
97); C) 1999/00 (no new variant); and D) 2003/04 (A/Fujian/411/02).
doi:10.1371/journal.pone.0007671.g003
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